Abstract:Backgrounds: Omentin-1 is a novel cytokine that is primarily released by the epicardial adipose tissue. Molecular structure analysis revealed that it contained a fibrinogen-like domain. Clinical studies have demonstrated that the expression of omentin-1 is tightly associated with the development of cardiovascular diseases, but the receptor by which omentin-1 modulates macrophage function has not been identified yet. Objective: This study sought to investigate the effect of omentin-1 on already-established atherosclerosis (AS) lesions in both ApoE−/− and Ldlr −/− mice and further, study its underlying mechanisms. Methods and Results: We investigated the effect of omentin-1 on the plaque phenotype by implanting a minipump in ApoE−/− and Ldlr −/− mice. In vivo studies showed that the infusion of omentin-1 increased the collagen content and mitigated the formation of the necrotic core in both animal models. Immunohistochemistry and immunofluorescence analysis revealed that omentin-1 suppressed inflammatory cytokines expression, macrophage infiltration, and apoptosis within the plaque. An immunoprecipitation experiment and confocal microscopy analysis confirmed the binding of omentin-1 to the integrin receptors αvβ3 and αvβ5. The cell studies demonstrated that omentin-1 suppressed the apoptosis and inflammatory cytokines expression induced by the oxidized low-density lipoprotein in the macrophage. In addition, omentin-1 promoted the phosphorylation of the integrin-relevant signaling pathway as well as the Akt and AMPK in the macrophage. The addition of the inhibitor of the integrin receptor or interfering with the expression of the integrin subunit αv (ITGAV) both significantly abrogated the bioeffects induced by omentin-1. A flow cytometry analysis indicated that the antibodies against αvβ3 and αvβ5 had a competitive effect on the omentin-1 binding to the cell membrane. Conclusions: The administration of adipokine omentin-1 can inhibit the necrotic cores formation and pro-inflammatory cytokines expression within the AS lesion. The mechanisms may include the suppression of apoptosis and pro-inflammatory cytokines expression in the macrophage by binding to the integrin receptors αvβ3 and αvβ5.

Research progress of omentin-1 in lipid metabolism-related diseases

Omentin-1: a newly discovered warrior against metabolic related diseases

Omentin-A Novel Adipokine in Respiratory Diseases

Omentin1 Ameliorates Myocardial Ischemia-Induced Heart Failure Via SIRT3/FOXO3a-dependent Mitochondrial Dynamical Homeostasis and Mitophagy.

Omentin: A Key Player in Glucose Homeostasis, Atheroprotection, and Anti-Inflammatory Potential for Cardiovascular Health in Obesity and Diabetes

Omentin-1: Protective impact on ischemic stroke via ameliorating atherosclerosis

Omentin-1 Ameliorates the Attachment of the Leukocyte THP-1 Cells to HUVECs by Targeting the Transcriptional Factor KLF2.

Omentin-1 Modulates Macrophage Function via Integrin Receptors αvβ3 and αvβ5 and Reverses Plaque Vulnerability in Animal Models of Atherosclerosis

Omentin-1 Attenuates Arterial Calcification and Bone Loss in Osteoprotegerin-Deficient Mice by Inhibition of RANKL Expression.

The adipocytokine omentin and its relationship with atherosclerosis

Progress in Adiponectin

Omentin-1 ameliorates pulmonary arterial hypertension by inhibiting endoplasmic reticulum stress through AMPKα signaling

Omentin-1 prevents inflammation-induced osteoporosis by downregulating the pro-inflammatory cytokines

Expression of Omentin in Intestine of Mice Before and after Oral Glucose Uptake and Effects of Omentin on Insulin Sensitivity in C2C12 Myotubes

Counteractive effects of omentin-1 against atherogenesis†

Adipose Tissue-Derived Omentin-1 Attenuates Arterial Calcification Via AMPK/Akt Signaling Pathway.

Therapeutic Effects of Omentin-1 on Pulmonary Fibrosis by Attenuating Fibroblast Activation Via AMP-Activated Protein Kinase Pathway

Omentin-1, a New Adipokine, Promotes Apoptosis Through Regulating Sirt1-dependent P53 Deacetylation in Hepatocellular Carcinoma Cells.

Omentin‑1 Induces Osteoblast Viability and Differentiation Via the TGF‑β/Smad Signaling Pathway in Osteoporosis.

Omentin-1 drives cardiomyocyte cell cycle arrest and metabolic maturation by interacting with BMP7

Expression and its clinical significance of plasma omentin-1 in patients with coronary heart disease and central obesity